 |
|
Prognostic comparison of Behcet's disease with or without HLA-Bw 51 antigen.
Man Soo Kim, Jae Ho Kim
Korean J Ophthalmol. 1989;3(2):85-89. Published online 1989 Dec 30 DOI: https://doi.org/10.3341/kjo.1989.3.2.85
|
|
Citations to this article as recorded by
 Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network
Carla Gaggiano, Abdurrahman Tufan, Silvana Guerriero, Gaafar Ragab, Jurgen Sota, Stefano Gentileschi, Stefania Costi, Ibrahim A. Almaghlouth, Andrea Hinojosa-Azaola, Samar Tharwat, Petros P. Sfikakis, Giuseppe Lopalco, Matteo Piga, Giovanni Conti, George
Ophthalmology and Therapy.2024;[Epub] CrossRef HLA-B51 Carriers are Susceptible to Ocular Symptoms of Behçet Disease and the Association between the Two Becomes Stronger towards the East along the Silk Road: A Literature Survey
Yukihiro Horie, Akira Meguro, Tohru Ohta, Eun Bong Lee, Kenichi Namba, Kazuomi Mizuuchi, Daiju Iwata, Nobuhisa Mizuki, Masao Ota, Hidetoshi Inoko, Susumu Ishida, Shigeaki Ohno, Nobuyoshi Kitaichi
Ocular Immunology and Inflammation.2017; 25(1): 37. CrossRef Relationships of HLA-B51 or B5 genotype with Behçet's disease clinical characteristics: systematic review and meta-analyses of observational studies
Carla Maldini, Michael P. LaValley, Morgane Cheminant, Mathilde de Menthon, Alfred Mahr
Rheumatology.2012; 51(5): 887. CrossRef Mucosal presentation of Behçet's disease
Graeme Moyle, Sue Chard, Fiona Boag
Journal of the European Academy of Dermatology and Venereology.1993; 2(2): 128. CrossRef
|